WOE TO HIM: Billionaire Blamed For Opioid Crisis Patents New Drug To Fight Opioid Addiction

WOE TO HIM: Billionaire Blamed For Opioid Crisis Patents New Drug To Fight Opioid Addiction

Billionaire Blamed For Opioid Crisis Patents New Drug To Fight Opioid Addiction

Submitted by AntiMedia

A member of the billionaire family that owns Purdue Pharmaceuticals, which is currently the target of multiple lawsuits over its complicity in perpetuating the opioid crisis, just received rights to a patent for a drug intended to curb the opioid crisis.

Dr. Richard Sackler is listed as one of six inventors of the patent, which was approved in January but came to light this week in a report from the Financial Times. The patent office granted the rights to Rhodes Pharmaceuticals, a subsidiary of Purdue.

The patent is for a new version of the drug buprenorphine, which is already FDA approved in tablet and film form. The new version would come in wafer form, meaning it can dissolve more quickly. According to claims in the patent, the faster the treatment dissolves, the less risk of diversion among addicts.

MORE HERE:

Billionaire Blamed For Opioid Crisis Patents New Drug To Fight Opioid Addiction

Print Friendly, PDF & Email
0

Leave a Reply

Your email address will not be published. Required fields are marked *